Éditeur(s) : HAL CCSD
Résumé : International audience
Science & Sports

hal-01622939
https://hal-umontpellier.archives-ouvertes.fr/hal-01622939
DOI : 10.1016/S0765-1597(02)00065-5

Éditeur(s) : HAL CCSD Springer Verlag
Résumé : International audience
ISSN: 1439-6319

hal-01622955
https://hal-umontpellier.archives-ouvertes.fr/hal-01622955
DOI : 10.1007/s00421-002-0637-x

Éditeur(s) : HAL CCSD Public Library of Science
Résumé : International audience
Growth hormone (GH) may stimulate water loss during exercise by activating sweating. This study investigated GH secretion and water loss during sequential cycling and running, taking postural changes into account. The two exercise segments had similar durations and were performed at the same relative intensity to determine their respective contributions to water loss and the plasma volume variation noted in such trials. Eight elite triathletes first performed an incremental cycle test to assess maximal oxygen consumption. Then, the triathletes performed one of two trials in randomized order: constant submaximal cycling followed by treadmill running (C 1 –R 2) or an inversed succession of running followed by cycling (R 1 –C 2). Each segment of both trials was performed for 20 minutes at ,75% of maximal oxygen consumption. The second trial, reversing the segment order of the first trial, took place two weeks later. During cycling, the triathletes used their own bicycles equipped with a profiled handlebar. Blood sampling (for GH concentrations, plasma viscosity and plasma volume variation) was conducted at rest and after each segment while water loss was estimated from the post-and pre-measures. GH increases were significantly lower in R 2 than C 2 (72.2650.1 vs. 164.06157 ng.ml 21 .min 21 , respectively; P,0.05). Water loss was significantly lower after C 1 –R 2 than R 1 –C 2 (11056163 and 12356153 ml, respectively; P,0.05). Plasma volume variation was significantly negative in C 1 and R 1 (26.1562.0 and 23.1665.0%, respectively; P,0.05), not significant in C 2 , and significantly positive for seven subjects in R 2 (4.0563.1%). We concluded that the lower GH increases in R 2 may have contributed to the smaller reduction in plasma volume by reducing sweating. Moreover, this lower GH response could be explained by the postural change during the transition from cycling to running. We recommend to pay particular attention to their hydration status during R 1 which could limit a potential dehydration during C 2 .
ISSN: 1932-6203

hal-01136734
https://hal.univ-antilles.fr/hal-01136734
https://hal.univ-antilles.fr/hal-01136734/document
https://hal.univ-antilles.fr/hal-01136734/file/Galy%20et%20al.%20-%202014%20-%20Sequential%20exercise%20in%20triathletes%20Variations%20in%20GH%20and%20water%20loss.pdf
DOI : 10.1371/journal.pone.0096145

Éditeur(s) : HAL CCSD Thieme Publishing
Résumé : International audience
The aim of the present study was to compare the effects of prior cycling and a successive run on respiratory muscle performance during a cycle-run succession as performed in the triathlon. We hypothesized that despite the moderate intensity of exercise and the absence of exhaustion, the crouched cycling position would induce a decrease in respiratory muscle performance that would be reversed by the successive vertical run position. Ten male triathletes (22.6 +/- 1.1 yr) performed a four-trial protocol: (1) an incremental cycle test to assess maximal oxygen uptake (VO2max), (2) 20 min of cycling (C), (3) 20 min of running (R), and (4) 20 min of cycling followed by 20 min of running (C-R). Trials 2, 3 and 4 were performed at the same metabolic intensity, i. e., 75 % of VO2max. Respiratory muscle force was assessed by measuring maximal expiratory (P(Emax)) and inspiratory (P(Imax)) pressures from the functional residual capacity (FRC) before and 10 min after C, R, and C-R. Respiratory muscle endurance was assessed one day before and 30 min after C, R, and C-R, by measuring the time limit (T(lim)), which corresponds to the length of time a respiratory load can be sustained before the process of fatigue develops sufficiently to cause task failure. The results showed a similar significant decrease in P(Imax) (132.4 +/- 4.9 versus 125.7 +/- 5.6 cm H2O, p < 0.05) and T(lim) (5.22 +/- 0.28 versus 3.68 +/- 0.32 min, p < 0.05) post-C and post-C-R (133.7 +/- 4.0 versus 126.9 +/- 5.2 cm H2O, and 5.29 +/- 0.18 versus 3.49 +/- 0.41 min, respectively, p < 0.05) compared with the pre-trial values. In contrast, P(Imax) and T(lim) were not significantly decreased post-R (131.8 +/- 6.1 cm H2O versus 129.6 +/- 6.4 cm H2O, and 4.90 +/- 0.69 versus 4.40 +/- 0.56 min, respectively, p > 0.05). We concluded that moderate intensity exercise not performed to exhaustion induced a decrease in respiratory muscle performance. Moreover, the respiratory muscle fatigue induced by prior cycling was maintained, and neither reversed nor worsened, by the successive run.
ISSN: 0172-4622

hal-01622938
https://hal-umontpellier.archives-ouvertes.fr/hal-01622938
DOI : 10.1055/s-2003-37201
PUBMED : 12582954

Éditeur(s) : HAL CCSD Human Kinetics
Résumé : International audience
Purpose: Postexercise alveolar-capillary membrane-diffusing capacity (DLco) often decreases in highly trained endurance athletes and seems linked to their training status. To test the hypothesis that training status influences postexercise DLco, 13 male and 2 female triathletes (20.2 ± 4.4 y old, 175.2 ± 6.7 cm tall; weight in a range of 66.6 ± 7.4 kg to 67.4 ± 7.8 kg during the 1-y study) were randomized into experimental (n = 7) and control (n = 8) groups and performed VO2max cycle tests and simulated cycle-run successions (CR) of 30 min + 20 min after 3 periods in the competitive season. Methods: Both groups were tested before (pre- HTP) and after a 30-wk high-training period (HTP) with high training volume, intensity, and frequency. The experimental group was then also tested after a 6-wk low-training period (LTP) with low training volume, intensity, and frequency, while the control group continued training according to the HTP schedule for these 6 wk. Ventilatory data were collected continuously. DLco testing was performed before and 30, 60, and 120 min after the CR trials. Results: Whatever the period or group, DLco was significantly decreased 30 min after CR, with a significantly greater decrease in the experimental group than the control group in LTP (–15.7% and –9.3% of DLco, respectively). Conclusions: Six weeks of low training volume and intensity were sufficient to reverse the effects of high training volume and intensity on the alveolar-capillary membrane after a CR succession in competitive triathletes.
ISSN: 1555-0265

hal-01163434
https://hal.univ-antilles.fr/hal-01163434

Éditeur(s) : HAL CCSD American Medical Association (AMA)
Résumé : International audience
IMPORTANCE Although frequently used in treating intensive care unit (ICU) patients with sepsis, empirical antifungal therapy, initiated for suspected fungal infection, has not been shown to improve outcome. OBJECTIVE To determine whether empirical micafungin reduces invasive fungal infection (IFI)-free survival at day 28. DESIGN, SETTING, AND PARTICIPANTS Multicenter double-blind placebo-controlled study of 260 nonneutropenic, nontransplanted, critically ill patients with ICU-acquired sepsis, multiple Candida colonization, multiple organ failure, exposed to broad-spectrum antibacterial agents, and enrolled between July 2012 and February 2015 in 19 French ICUs. INTERVENTIONS Empirical treatment with micafungin (100mg, once daily, for 14 days) (n = 131) vs placebo (n = 129). MAIN OUTCOMES AND MEASURES The primary end pointwas survival without proven IFI 28 days after randomization. Key secondary end points included new proven fungal infections, survival at day 28 and day 90, organ failure, serum (1-3)-beta-D-glucan level evolution, and incidence of ventilator-associated bacterial pneumonia. RESULTS Among 260 patients (mean age 63 years; 91 [35%] women), 251 (128, micafungin group; 123, placebo group) were included in the modified intent-to-treat analysis. Median values were 8 for Sequential Organ Failure Assessment (SOFA) score, 3 for number of Candida-colonized sites, and 99 pg/mL for level of (1-3)-beta-D-glucan. On day 28, there were 82 (68%) patients in the micafungin group vs 79 (60.2%) in the placebo group who were alive and IFI free (hazard ratio [HR], 1.35 [95% CI, 0.87-2.08]). Results were similar among patients with a (1-3)-beta-D-glucan level of greater than 80 pg/mL (n = 175; HR, 1.41 [95% CI, 0.85-2.33]). Day-28 IFI-free survival in patients with a high SOFA score (> 8) was not significantly different when compared between the micafungin vs placebo groups (HR, 1.69 [95% CI, 0.96-2.94]). Use of empirical micafungin decreased the rate of new invasive fungal infection in 4 of 128 patients (3%) in the micafungin group vs placebo (15/123 patients [12%]) (P =.008). CONCLUSIONS AND RELEVANCE Among nonneutropenic critically ill patients with ICU-acquired sepsis, Candida species colonization at multiple sites, and multiple organ failure, empirical treatment with micafungin, compared with placebo, did not increase fungal infection-free survival at day 28.
ISSN: 0098-7484

hal-01405822
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01405822
DOI : 10.1001/jama.2016.14655
PUBMED : 27706483

Éditeur(s) : HAL CCSD International Federation of Sports Medicine
Résumé : International audience
To study the exercise-induced arterial hypoxaemia (EIAH) kinetics in a world class Ironman triathlete at ventilatory threshold (TH vent), the authors simulated the cycle-run succession (CR, 20 min + 20 min) and a 20-min isolated run (R). Although 'moderate EIAH' was noted during CR, the SpO 2 kinetics of the isolated R reflected 'severe EIAH' from minutes 7 to 15 with a nadir of 85 % SpO 2 that stabilised at 90 % SpO 2 from minute 15 on. The physiological processes involved in these responses are discussed. These data indicate a systematic 'moderate EIAH' in a world class Ironman champion during CR and R at TH vent and a temporary 'severe EIAH' during R, which was attenuated when running was successive to cycling. The physiological significance of this phenomenon remains unclear, however, and further experiments are needed.
ISSN: 1528-3356

hal-01152346
https://hal.univ-antilles.fr/hal-01152346

Éditeur(s) : HAL CCSD
Résumé : International audience
Chronic obstructive pulmonary disease (COPD) is the chronic respiratory disease with the most important burden on public health in terms of morbidity, mortality and health costs. For patients, COPD is a major source of disability because of dyspnea, restriction in daily activities, exacerbation, risk of chronic respiratory failure and extra-respiratory systemic organ disorders. The previous French Language Respiratory Society (SPLF) guidelines on COPD exacerbations were published in 2003. Using the GRADE methodology, the present document reviews the current knowledge on COPD exacerbation through 4 specific outlines: (1) epidemiology, (2) clinical evaluation, (3) therapeutic management and (4) prevention. Specific aspects of outpatients and inpatients care are discussed, especially regarding assessment of exacerbation severity and pharmacological approach.
Revue Des Maladies Respiratoires

hal-01560287
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01560287
DOI : 10.1016/j.rmr.2017.03.034
PUBMED : 28552256

Éditeur(s) : HAL CCSD Oxford University Press (OUP)
Résumé : International audience
ISSN: 0305-7453

hal-01470808
https://hal.archives-ouvertes.fr/hal-01470808
DOI : 10.1093/jac/dkw352
PUBMED : 27609051